Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy

The Lancet Infectious Diseases

Volumn 10, Issue 7, 2010, Pages 499-503

  Cagigi, Alberto ^a   Nilsson, Anna ^a   Pensieroso, Simone ^a   Chiodi, Francesca ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953643545     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70117-1     Document Type: Note

References (66)

1. Arpadi S.M., Markowitz L.E., Baughman A.L., et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 97 (1996) 653-657
2. Kroon F.P., van Dissel J.T., de Jong J.C., and van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 8 (1994) 469-476
3. Janoff E.N., Douglas Jr. J.M., Gabriel M., et al. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 158 (1988) 983-990
4. Janoff E.N., Hardy W.D., Smith P.D., and Wahl S.M. Humoral recall responses in HIV infection: Levels, specificity, and affinity of antigen-specific IgG. J Immunol 147 (1991) 2130-2135
5. Agematsu K. Memory B cells and CD27. Histol Histopathol 15 (2000) 573-576
6. Agematsu K., Hokibara S., Nagumo H., and Komiyama A. CD27: a memory B-cell marker. Immunol Today 21 (2000) 204-206
7. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
8. Tangye S.G., Avery D.T., and Hodgkin P.D. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol 170 (2003) 261-269
9. Ballet J.J., Sulcebe G., Couderc L.J., et al. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 68 (1987) 479-487
10. Kroon F.P., van Dissel J.T., Rijkers G.T., Labadie J., and van Furth R. Antibody response to Haemophilus influenzae type b vaccine in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 25 (1997) 600-606
11. Kroon F.P., Rimmelzwaan G.F., Roos M.T., et al. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12 (1998) F217-F223
12. Kroon F.P., van Dissel J.T., Ravensbergen E., Nibbering P.H., and van Furth R. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations. Vaccine 18 (1999) 524-530
13. Kroon F.P., van Dissel J.T., Ravensbergen E., Nibbering P.H., and van Furth R. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi). Vaccine 17 (1999) 2941-2945
14. Kroon F.P., van Dissel J.T., de Jong J.C., Zwinderman K., and van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 18 (2000) 3040-3049
15. Malaspina A., Moir S., Orsega S.M., et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 191 (2005) 1442-1450
16. Nielsen H., Kvinesdal B., Benfield T.L., Lundgren J.D., and Konradsen H.B. Rapid loss of specific antibodies after pneumococcal vaccination in patients with human immunodeficiency virus-1 infection. Scand J Infect Dis 30 (1998) 597-601
17. De Milito A., Morch C., Sonnerborg A., and Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15 (2001) 957-964
18. De Milito A., Nilsson A., Titanji K., et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103 (2004) 2180-2186
19. Chong Y., Ikematsu H., Yamamoto M., et al. Increased frequency of CD27- (naive) B cells and their phenotypic alteration in HIV type 1-infected patients. AIDS Res Hum Retroviruses 20 (2004) 621-629
20. Titanji K., De Milito A., Cagigi A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108 (2006) 1580-1587
21. Weiss P.J., Wallace M.R., Oldfield III E.C., O'Brien J., and Janoff E.N. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine. J Infect Dis 171 (1995) 1217-1222
22. Amanna I.J., Carlson N.E., and Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357 (2007) 1903-1915
23. Titanji K., Chiodi F., Bellocco R., et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 19 (2005) 1947-1955
24. Moir S., Malaspina A., Ogwaro K.M., et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci USA 98 (2001) 10362-10367
25. Ng V.L., Hurt M.H., Fein C.L., et al. IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis. Blood 83 (1994) 1067-1078
26. Wood C., and Harrington Jr. W. AIDS and associated malignancies. Cell Res 15 (2005) 947-952
27. Wilkins B.S., Davis Z., Lucas S.B., Delsol G., and Jones D.B. Splenic marginal zone atrophy and progressive CD8+ T-cell lymphocytosis in HIV infection: a study of adult post-mortem spleens from Côte d'Ivoire. Histopathology 42 (2003) 173-185
28. Hufert F.T., van Lunzen J., Janossy S., et al. Germinal centre CD4+ T cells are an important site of HIV-1 replication in vivo. AIDS 11 (1997) 849-857
29. Koopman G., Taher T.E., Mazzucchelli I., et al. CD44 isoforms, including the CD44 V3 variant, are expressed on endothelium, suggesting a role for CD44 in the immobilization of growth factors and the regulation of the local immune response. Biochem Biophys Res Commun 245 (1998) 172-176
30. Allen C.D., Okada T., Tang H.L., and Cyster J.G. Imaging of germinal center selection events during affinity maturation. Science 315 (2007) 528-531
31. Allen C.D., Ansel K.M., Low C., et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 9 (2004) 943-952
32. Okada T., Ngo V.N., Ekland E.H., et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 196 (2002) 65-75
33. Widney D.P., Breen E.C., Boscardin W.J., et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 25 (2005) 702-706
34. Cagigi A., Mowafi F., Dang L.P., et al. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood 112 (2008) 4401-4410
35. Honczarenko M., Douglas R.S., Mathias C., Lee B., Ratajczak M.Z., and Silberstein L.E. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 94 (1999) 2990-3008
36. Brandes M., Legier D.F., Spoerri B., Schaerli P., and Moser B. Activation-dependent modulation of B-lymphocyte migration to chemokines. Int Immunol 12 (2000) 1285-1292
37. Moir S., Ho J., Malaspina A., et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205 (2008) 1797-1805
38. Salazar-Gonzalez J.F., Martinez-Maza O., Nishanian P., et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis 178 (1998) 423-430
39. Hazenberg M.D., Hamann D., Schuitemaker H., and Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 1 (2000) 285-289
40. Berberian L., Goodglick L., Kipps T.J., and Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261 (1993) 1588-1591
41. Juompan L., Lambin P., and Zouali M. Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection. Faseb J 12 (1998) 1473-1480
42. Huang L., Li C.J., and Pardee A.B. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes. Biochem Biophys Res Commun 237 (1997) 461-464
43. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2 (2004) 11-21
44. Pan-Hammarstrom Q., Zhao Y., and Hammarstrom L. Class switch recombination: a comparison between mouse and human. Adv Immunol 93 (2007) 01-61
45. He B., Qiao X., Klasse P.J., et al. HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J Immunol 176 (2006) 3931-3941
46. Qiao X., He B., Chiu A., Knowles D.M., Chadburn A., and Cerutti A. Human Immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol 7 (2006) 302-310
47. Popovic M., Tenner-Racz K., Pelser C., et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA 102 (2005) 14807-14812
48. Cagigi A., Du L., Dang L.V., et al. CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection. PLoS One 4 (2009) e5427
49. Fecteau J.F., Cote G., and Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177 (2006) 3728-3736
50. Sharland M., Blanche S., Castelli G., Ramos J., and Gibb D.M. PENTA guidelines for the use of antiretroviral therapy, 2004. HIV Med 5 suppl 2 (2004) 61-86
51. Pensieroso S., Cagigi A., Palma P., et al. Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci USA 106 (2009) 7939-7944
52. Moreton J. MMR vaccination: protecting our children. J Fam Health Care 12 (2002) 31
53. Palma P., Romiti M.L., Cancrini C., et al. Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants. Vaccine 26 (2008) 5196-5201
54. Zanchetta M., Anselmi A., Vendrame D., et al. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther 13 (2008) 47-55
55. Romiti M.L., Cancrini C., Castelli-Gattinara G., et al. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART. AIDS 15 (2001) 2075-2084
56. King Jr. J.C. Community respiratory viruses in individuals with human immunodeficiency virus infection. Am J Med 102 (1997) 19-24
57. Fuller J.D., Craven D.E., Steger K.A., Cox N., Heeren T.C., and Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 28 (1999) 541-547
58. Lin J.C., and Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 161 (2001) 441-446
59. Neuzil K.M., Reed G.W., Mitchel Jr. E.F., and Griffin M.R. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 281 (1999) 901-907
60. Tasker S.A., O'Brien W.A., Treanor J.J., et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine 16 (1998) 1039-1042
61. Tasker S.A., Treanor J.J., Paxton W.B., and Wallace M.R. Efficacy of influenza vaccination in HIV-infected persons: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 131 (1999) 430-433
62. Campos-Loza A, Soto-Ramirez L, Sierra-Madero J, et al. The 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010); San Diego, USA; Feb 16-19, 2010 (abstr 801).
63. Reyes-Terán G, de la Rosa-Zamboni D, Ormsby C, et al. The 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010); San Diego, USA; Feb 16-19, 2010 (abstr 803LB).
64. Koegelenberg C.F., Irusen E.M., Cooper R., et al. High mortality from respiratory failure secondary to swine-origin influenza A (H1N1) in South Africa. QJM 103 (2010) 319-325
65. Bickel M, Wieters I, von Hentig N, et al. The 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010); San Diego, USA; Feb 16-19, 2010 (abstr 806LB).
66. Kunisaki K.M., and Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9 (2009) 493-504